MaxCyte, Inc. names Cenk Sumen Chief Scientific Officer


MaxCyte, Inc., a leading commercial cell-engineering company, announced that NYU Tandon Adjunct Professor Cenk Sumen as Chief Scientific Officer. “I am driven by scientific innovation and working with visionary companies that truly make a beneficial impact on the health of humanity,” said Sumen.